TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: ad libitum energy intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: RT-PCR results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Anxiety measured by Visual Analog Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Depression scores on the PHQ-9
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety scores from the GAD-7
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 5-D itch scale questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Dermatology Life Quality Index questionnaire (DLQI)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Hospital anxiety and depression questionnaire (HAD)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Acylcarnitine profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of patients with drug-related adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum decrease from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Δ of urinary oxalate excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Metabolic availability of methionine and lysine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Subjects readmitted to the ICU for pulmonary complications
Endpoint domain: Mortality/survival
Primary endpoint: percentage of patients with major relapse
Endpoint domain: Mortality/survival
Primary endpoint: Surgeons Image Rating (SIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events up to 30 days post procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Mini - Asthma Quality of Life Questionnaire (AQLQ)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Psychological Outcome Profiles
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Session Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: DHA level in RBC lipid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: DHA level in faecal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: denture adaptation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: occurrence of vURTI episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Microwebsite Visits 2 Weeks
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Microwebsite Visits 4 Weeks
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Appointment Claims 3 Months
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Appointment Claims 6 Months
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of fracture detected by AI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in sputum mycobacterial load over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with treatment emergent abnormality in 12-lead electrocardiogram (ECG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients with inappropriate referrals
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Participant AK Lesion Clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Post-traumatic Stress Disorder Short Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: incidence of dose limiting toxicity (grade >= 3)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in IL-6/GP-130/STAT3 pathway expression (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: General and specific quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Coma recovery scale-revised (CRS-R)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sensitivity and specificity of T2MR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in functional assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in range of motion in upper and lower limb by goniometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hammersmith Functional Motor Scale Expanded
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac functionality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in the visual Benamer Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average change in rate of mucociliary clearance (MCC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Brain Insulin Resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Peripheral insulin resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Incidence of specific AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Blood glucose fasting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood glucose at 20, 40, 60, 90 and 120 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: compliance of patient
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients that relapse
Endpoint domain: Adverse events/effects
Primary endpoint: Symptoms associated with TKI administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preservation of presence of red flare
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calculation of cumulative urinary and fecal recovery of total radioactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arizona Sexual Experiences Scale- Female (ASES-F)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes of physical activity behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Affective responses to physical activity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adherence to the physical activity program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in opsonophagocytic assay (OPA) geometric mean titers (GMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Immunoglobulin G (IgG) geometric mean concentrations (GMC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Infant Growth (Length)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infant Growth (Weight)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum hsCRP (High-Sensitivity C-Reactive Protein)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of vital pulp therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety levels measured by the Spielberger State-Trait Anxiety Inventory (STAI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maternal attachment measured by the Maternal Attachment Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Breastfeeding self-efficacy measured by the Postnatal Breastfeeding Self-Efficacy Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Lipid profile TG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lipid profile HDL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve (AUC0-24) of Ethinyl Estradiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Concentration (Cmax) of Ethinyl Estradiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of Maximum Observed Concentration (Tmax) of Ethinyl Estradiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve (AUC0-24) of Drospirenone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Concentration (Cmax) of Drospirenone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in migraine-related disability
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Incidence of vocal folds dysplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IL-32 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lung Imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Delineation of upper extremity lymphatics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Genetic Counseling Attendance
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Percent time in the set SpO2 target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percent time at SpO2 ≤80% and >98%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Safety of H-coil dTMS treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Discrimination capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reproducibility of performance tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Analysis relationships between Performance Outcomes, Patient-Reported Outcome and Clinical Outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diagnosis of primary caries lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of ST-SBRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of clinically useful mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Profile From Time 0 to 6 Hours (AUC6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal Clearance (CLr)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Safety of Fluselenamy PET Imaging
Endpoint domain: Adverse events/effects
Primary endpoint: Change in range of motion in loaded dorsal flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of study subjects with treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in mean percentage bronchial wall area (%WA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rating of Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of perinatal mortality
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of major neonatal morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neonatal outcomes
Primary endpoint: Change on the Leuven-postprandial distress scale (LPDS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Successful videolaryngoscopic endotracheal intubation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of clinically significant ECG findings
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of clinically significant vital signs
Endpoint domain: Adverse events/effects
Primary endpoint: Cervical Joint Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of prostate lesions determined to be cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Body Rotation Angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local tumor control rate at 90 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Ileal-associated microbiota engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suicide Risk Markers
Endpoint domain: Adverse events/effects
Primary endpoint: Consumption of hydromorphone
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Detection of digestive occlusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Patient satisfaction with bowel prep
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Efficacy of the bowel prep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Positive SARS-CoV-2 seroresponse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change of active cervical range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSF volume increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: G8 (Geriatric 8) screening tool measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CARG (Cancer and Aging Research Group) chemotherapy toxicity score measurement
Endpoint domain: Adverse events/effects
Primary endpoint: VES-13 (Vulnerable Elders Survey-13) measurement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Uptake and persistence of CABLA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Staging accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Toxoplasma igG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic yield of brain scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Histological profile of induced membrane fragments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cellular profile of induced membrane fragments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Secretory profile of induced membrane fragments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gene expression profile of induced membrane fragments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first all-cause readmission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Management of acute uncomplicated diverticulitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Time to sustained clinical recovery from COVID-19 symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects with abnormal and clinically significant abnormal hematology values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: PR interval in ECG Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Baseline of heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Functional Vital Capacity (FVC) in the Lung Function test assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Strengths & Difficulties Questionnaire (SDQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Child Behavior Checklist 1½-5 (CBCL)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Surgeon Recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of participants with death by day-30 post-plasma therapy
Endpoint domain: Mortality/survival
Primary endpoint: proportion of participants with refractoriness by day-30 post-plasma therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of participants with ADAMTS13 activity < 20% by day-30 post-plasma therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Female sexual function index (FSFI) score
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Sexual Quality of Life Questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in pain-related catastrophizing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical improvement of ARDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Blinding feasibility of participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychosocial Functioning Inventory (PFI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: World Health Organization (WHO)-Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Satisfaction with Life and social Functioning
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Prevalence of Rouvière's Sulcus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma C-reactive protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete absence of wheals and itching
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: BREAST-Q questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Appetite feelings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Food reward
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Mean Treatment Burden Score (Baseline to Month 6)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Mean Treatment Burden Score (Baseline to Month 12)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: DAS28-C-reactive Protein (CRP) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Erythrocyte sedimentation rate (ESR) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HbA1c change from baseline (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mineral bone disease progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean SCN activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time point of peak SCN activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time point of trough SCN activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amplitude of SCN activity rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Axillary recurrence-free survival
Endpoint domain: Mortality/survival
Primary endpoint: mean diurnal intraocular pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Understandability of the material
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Actionability of the material
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality of the material
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Trunk Rotation Degree - Angle of Trunk Rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coronal Balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects achieving PASI 75 reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of subjects achieving sPGA clearance or very slight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Thalamic NAA level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients included
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Technical errors during laparoscopic cholecystectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in BAYLEY-4 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: surgical field scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Degree of sustained CR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TRE sustainability
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Natremia measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hydration saliva measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes